Clinical Pharmacology of Electronic Nicotine Delivery Systems (ENDS): Implications for Benefits and Risks in the Promotion of the Combusted Tobacco Endgame.
Population Clinical
Population Health Impact
Benowitz (2021)
Young Adults’ Vaping, Readiness to Quit, and Recent Quit Attempts: The Role of Co-use With Cigarettes and Marijuana.
Population Clinical
Cessation
ENDS
Berg (2021)
Cigarette‒E-cigarette Transitions and Respiratory Symptom Development.
Population Clinical
Likelihood Of Use
Berlowitz (2023)
Electronic Cigarettes for Smoking Cessation: The Gap Between Behavior in Smokers and Medical Education.
Population Clinical
Cessation
Tobacco
Bernstein (2022)
Reduced-risk warnings versus the US FDA-mandated addiction warning: The effects of e-cigarette warning variations on health risk perceptions.
Population Clinical
Effect Of Packaging & Labelling On Perception Of Risk
Berry (2019)
Predictors of polysubstance vaping in emerging adults.
Population Clinical
Consumer Use
Factors Influencing Pattern Of Use
Bessenyei and Yakovenko (2023)
An Evaluation of the Contextual and Motivational Factors Associated with the Choice to Use Either Tobacco or Electronic Cigarettes in Dual Users.
Population Clinical
Consumer Use
Factors Influencing Pattern Of Use
Betts (2022)
Rates of electronic cigarette use among adults with a chronic mental illness.
Population Clinical
Consumer Use
Factors Influencing Pattern Of Use
Bianco (2019)
Cardiovascular Benefits of Switching From Tobacco to Electronic Cigarettes.
Population Clinical
Population Health Impact
Biondi Zoccai (2020)
Choice and Variety-Seeking of E-liquids and Flavor Categories by New Zealand Smokers Using an Electronic Cigarette:
Population Clinical
Consumer Use
Flavor Appeal
Blank (2021)